More on ASMB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+52.3% Growth)
- Ratings (6.4 Score)
- Holders

Upcoming Events

- Earnings (2/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Assembly Biosciences (NQ:ASMB)
Delayed: 28.27 +0.61 (2.21%)
Prev. Close $27.66  
Open$27.19 
52 Wk High$14.50 
52 Wk Low$4.33 
Day High$29.00 
Day Low$27.00 
P/E N/A  
EPS$0.00 
Volume90,648 

Friends, Peers and Foes (?): GILD (more...)

Feb 9, 2026 08:47 AM Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
Dec 22, 2025 08:02 AM Gilead exercises option for Assembly Bio's herpes treatment programs
Dec 22, 2025 08:00 AM Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
Dec 10, 2025 04:53 AM Assembly Biosciences (ASMB) PT Raised to $62 at Jefferies
Dec 8, 2025 04:18 PM Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 08
Dec 8, 2025 04:05 PM Assembly Biosciences reports positive herpes drug trial results
Dec 8, 2025 04:05 PM Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rat
Dec 8, 2025 11:43 AM Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: JANUS HENDERSON GROUP PLC
Nov 24, 2025 11:31 AM Form EFFECT ASSEMBLY BIOSCIENCES,
Nov 21, 2025 04:47 PM Form 424B3 ASSEMBLY BIOSCIENCES,
View All Articles

Entities mentioned with ASMB

View All Entities